Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.
The therapeutic benefits of cannabinoids remain unclear, especially when weighted against their adverse effects.
This review of clinical research reports the evidence regarding biomedical and behavioral treatments for psychostimulant withdrawal symptoms.
To understand what prescribing characteristics are associated with opioid overdose following buprenorphine taper.
The objectives of this study are to (1) identify changes introduced to OAT clinical guidelines in Ireland during the pandemic; and (2) develop consensus on whether the new recommendations should be
Discontinuation from benzodiazepines can be problematic for patients and may result in a withdrawal syndrome, which can be protracted and last months to years.
Certains droits réservés, La communauté de pratique nationale sur l’approvisionnement plus sécuritaire
Politique de confidentialité et conditions d’utilisation de nss-aps.ca | Politique d’accessibilité
